1.Melton, LJ 3rd. Selection bias in the referral of patients and the natural history of surgical conditions. Mayo Clinic Proceedings 1985; 60: 880–885.
2.Steckelberg, JM, et al. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. American Journal of Medicine 1990; 88: 582–588.
3.Kanafani, ZA, et al. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. European Journal of Clinical Microbiology and Infectious Diseases 2010; 10: 1203–1210.
4.Al-Hasan, MN, et al. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. American Journal of Medicine 2008; 121: 702–708.
6.Melton, LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clinic Proceedings 1996; 71: 266–274.
7.Tleyjeh, IM, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. Journal of the American Medical Association 2005; 293: 3022–3028.
8.Uslan, DZ, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Archives of Internal Medicine 2007; 167: 834–839.
9.Al-Hasan, MN, Eckel-Passow, JE, Baddour, LM. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. Journal of Infection 2010; 61: 28–33.
10.Kokmen, E, et al. Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. Journal of Clinical Epidemiology 1996; 49: 79–83.
11.Al-Hasan, MN, et al. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. Journal of Antimicrobial Chemotherapy 2009; 64: 169–174.
12.Madsen, KM, et al. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981–1994. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1999; 107: 346–352.
13.Decousser, JW, et al. Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007. Diagnostic Microbiology and Infectious Disease 2010; 66: 292–300.
14.Reacher, MH, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. British Medical Journal 2000; 320: 213–216.
15.Filice, GA, et al. Bacteremia in Charleston County, South Carolina. American Journal of Epidemiology 1986; 123: 128–136.
16.Skogberg, K, et al. Increase in bloodstream infections in Finland, 1995–2002. Epidemiology and Infection 2008; 136: 108–114.
17.Laupland, KB, et al. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiology and Infection 2007; 135: 1037–1042.
18.Gosbell, IB, Newton, PJ, Sullivan, EA. Survey of blood cultures from five community hospitals in south-western Sydney, Australia, 1993–1994. Australian and New Zealand Journal of Medicine 1999; 29: 684–692.
19.Diekema, DJ, Pfaller, MA, Jones, RN. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997–2000. International Journal of Antimicrobial Agents 2002; 20: 412–418.
20.Diekema, DJ, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. Journal of Clinical Microbiology 2003; 41: 3655–3660.
21.Jones, ME, et al. Emerging resistance among bacterial pathogens in the intensive care unit – European and North American Surveillance study (2000–2002). Annals of Clinical Microbiology and Antimicrobials 2004; 3: 14.
22.Pien, BC, et al. The clinical and prognostic importance of positive blood cultures in adults. American Journal of Medicine 2010; 123: 819–828.
23.Marchaim, D, et al. Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. European Journal of Clinical Microbiology and Infectious Diseases 2008; 27: 1045–1051.
24.Douglas, MW, et al. Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Tropical Medicine and International Health 2004; 9: 795–804.
25.Cockerill, FR 3rd, et al. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clinical Infectious Diseases 1997; 24: 403–418.
26.Corey, GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clinical Infectious Diseases 2009; 48: S254–S259.
27.Al-Hasan, MN, Eckel-Passow, JE, Baddour, LM. Bacteremia complicating gram-negative urinary tract infections: a population-based study. Journal of Infection 2010; 60: 278–285.
28.Paez, JI, Costa, SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. Journal of Hospital Infection 2008; 70: 101–108.
29.Metan, G, et al. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scandinavian Journal of Infectious Diseases 2006; 38: 527–531.
30.Cheong, HS, et al. Risk factors for mortality and clinical implications of catheter-related infections in patients with bacteraemia caused by Stenotrophomonas maltophilia. International Journal of Antimicrobial Agents 2008; 32: 538–540.
31.Paez, JG, et al. Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years. Infection Control and Hospital Epidemiology 2008; 29: 989–990.
32.Al-Hasan, MN, et al. Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998–2007. Clinical Microbiology and Infection 2010. Published online: 1 June 2010. doi:10.1111/j.1469-0691.2010.03277.x.
33.Al-Hasan, MN, et al. Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clinic Proceedings 2010; 85: 139–144.